BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu W, Sun XH. Janus kinase 3: the controller and the controlled. Acta Biochim Biophys Sin (Shanghai). 2012;44:187-196. [PMID: 22130498 DOI: 10.1093/abbs/gmr105] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 González M, Cerecetto H. Quinoxaline derivatives: a patent review (2006--present). Expert Opin Ther Pat 2012;22:1289-302. [PMID: 22971178 DOI: 10.1517/13543776.2012.724677] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
2 Di Matteo G, Chiriaco M, Scarselli A, Cifaldi C, Livadiotti S, Di Cesare S, Ferradini V, Aiuti A, Rossi P, Finocchi A, Cancrini C. JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene. Mol Genet Genomic Med 2018;6:713-21. [PMID: 30032486 DOI: 10.1002/mgg3.391] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
3 Coskun M, Salem M, Pedersen J, Nielsen OH. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol Res. 2013;76:1-8. [PMID: 23827161 DOI: 10.1016/j.phrs.2013.06.007] [Cited by in Crossref: 160] [Cited by in F6Publishing: 154] [Article Influence: 20.0] [Reference Citation Analysis]
4 Balupuri A, Balasubramanian PK, Cho SJ. 3D-QSAR, docking, molecular dynamics simulation and free energy calculation studies of some pyrimidine derivatives as novel JAK3 inhibitors. Arabian Journal of Chemistry 2020;13:1052-78. [DOI: 10.1016/j.arabjc.2017.09.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 12.0] [Reference Citation Analysis]
5 Pedersen J, Coskun M, Soendergaard C, Salem M, Nielsen OH. Inflammatory pathways of importance for management of inflammatory bowel disease. World J Gastroenterol 2014; 20(1): 64-77 [PMID: 24415859 DOI: 10.3748/wjg.v20.i1.64] [Cited by in CrossRef: 90] [Cited by in F6Publishing: 84] [Article Influence: 12.9] [Reference Citation Analysis]
6 Deng H, Xu X, Hu L, Li J, Zhou D, Liu S, Luo P, He J, Weng S. A janus kinase from Scylla paramamosain activates JAK/STAT signaling pathway to restrain mud crab reovirus. Fish & Shellfish Immunology 2019;90:275-87. [DOI: 10.1016/j.fsi.2019.03.056] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
7 García-Bermúdez M, López-Mejías R, Genre F, Castañeda S, Corrales A, Llorca J, González-Juanatey C, Ubilla B, Miranda-Filloy JA, Pina T, Gómez-Vaquero C, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, López-Longo FJ, Carreira P, Blanco R, Martín J, González-Gay MA. Lack of association between JAK3 gene polymorphisms and cardiovascular disease in Spanish patients with rheumatoid arthritis. Biomed Res Int 2015;2015:318364. [PMID: 25815310 DOI: 10.1155/2015/318364] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
8 Zhang H, Zhang YK, Wang YJ, Kathawala RJ, Patel A, Zhu H, Sodani K, Talele TT, Ambudkar SV, Chen ZS, Fu LW. WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells. Cancer Sci 2014;105:1071-8. [PMID: 24903205 DOI: 10.1111/cas.12462] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
9 Brooks AJ, Dehkhoda F, Kragelund BB. Cytokine Receptors. In: Belfiore A, Leroith D, editors. Principles of Endocrinology and Hormone Action. Cham: Springer International Publishing; 2018. pp. 157-85. [DOI: 10.1007/978-3-319-44675-2_8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
10 Wang YC, Cai D, Cui XB, Chuang YH, Fay WP, Chen SY. Janus Kinase 3 Deficiency Promotes Vascular Reendothelialization-Brief Report. Arterioscler Thromb Vasc Biol 2021;41:2019-26. [PMID: 33910370 DOI: 10.1161/ATVBAHA.121.316293] [Reference Citation Analysis]
11 Wang YC, Cui XB, Chuang YH, Chen SY. Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling. Arterioscler Thromb Vasc Biol 2017;37:1352-60. [PMID: 28473442 DOI: 10.1161/ATVBAHA.116.308895] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
12 Şahİn M, Aydin H, Altun A, Derİn ME, Şahİn A. The Effects of Tofacitinib-Mediated Janus Kinase/Signal Transducers and Activators of the Transcription Signal Pathway Inhibition on Collagen Biosynthesis in Hepatic and Skin Fibroblast Cell Culture. Arch Rheumatol 2020;35:343-50. [PMID: 33458657 DOI: 10.46497/ArchRheumatol.2020.7568] [Reference Citation Analysis]
13 Drokhlyansky E, Göz Aytürk D, Soh TK, Chrenek R, O'Loughlin E, Madore C, Butovsky O, Cepko CL. The brain parenchyma has a type I interferon response that can limit virus spread. Proc Natl Acad Sci U S A 2017;114:E95-E104. [PMID: 27980033 DOI: 10.1073/pnas.1618157114] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 6.4] [Reference Citation Analysis]
14 Babu S, Nagarajan SK, Madhavan T. Understanding the structural features of JAK2 inhibitors: a combined 3D-QSAR, DFT and molecular dynamics study. Mol Divers 2019;23:845-74. [PMID: 30617940 DOI: 10.1007/s11030-018-09913-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Guo Y, Arakawa F, Miyoshi H, Niino D, Kawano R, Ohshima K. Activated janus kinase 3 expression not by activating mutations identified in natural killer/T-cell lymphoma. Pathol Int 2014;64:263-6. [PMID: 24965108 DOI: 10.1111/pin.12166] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
16 Chi F, Chen L, Wang C, Li L, Sun X, Xu Y, Ma T, Liu K, Ma X, Shu X. JAK3 inhibitors based on thieno[3,2-d]pyrimidine scaffold: design, synthesis and bioactivity evaluation for the treatment of B-cell lymphoma. Bioorg Chem 2020;95:103542. [PMID: 31918398 DOI: 10.1016/j.bioorg.2019.103542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Kim JS, Kim MW, Kang SJ, Jeong HY, Park SI, Lee YK, Kim HS, Kim KS, Park YS. Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles. Int J Nanomedicine 2018;13:4817-30. [PMID: 30214190 DOI: 10.2147/IJN.S161932] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Qamar F, Junejo S, Qureshi S, Seleman M, Bainter W, Massaad M, Chou J, Geha RS. A novel mutation in the JH4 domain of JAK3 causing severe combined immunodeficiency complicated by vertebral osteomyelitis. Clinical Immunology 2017;183:198-200. [DOI: 10.1016/j.clim.2017.09.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Hatton N, Lintz E, Mahankali M, Henkels KM, Gomez-Cambronero J. Phosphatidic Acid Increases Epidermal Growth Factor Receptor Expression by Stabilizing mRNA Decay and by Inhibiting Lysosomal and Proteasomal Degradation of the Internalized Receptor. Mol Cell Biol 2015;35:3131-44. [PMID: 26124282 DOI: 10.1128/MCB.00286-15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]